genprowebdirectory
Facebook
Linkedin
RSS
Twitter
Youtube
GEN Edge
Featured News
Multimedia
News
Insights
Topics
Artificial Intelligence
Bioprocessing
Cancer
Drug Discovery
Genome Editing
Infectious Diseases
OMICs
Translational Medicine
Magazine
Browse Issues
Subscribe
Multimedia
Summits
Webinars
GEN Live
Learning Labs
Podcasts
Resources
A-Lists
eBooks/Perspectives
Tutorials
Peer-Reviewed Journals
GEN Biotechnology
Re:Gen Open
New Products
Conference Calendar
Subscribe
Get GEN Magazine
Get GEN eNewsletters
Search
Facebook
Linkedin
RSS
Twitter
Youtube
Sign in
Welcome! Log into your account
your username
your password
Forgot your password? Get help
Privacy Policy
Password recovery
Recover your password
your email
A password will be e-mailed to you.
GEN – Genetic Engineering and Biotechnology News
GEN Edge
Featured News
Multimedia
News
Insights
Topics
Artificial Intelligence
Bioprocessing
Cancer
Drug Discovery
Genome Editing
Infectious Diseases
OMICs
Translational Medicine
Magazine
Browse Issues
Subscribe
Multimedia
Summits
Webinars
GEN Live
Learning Labs
Podcasts
Resources
A-Lists
eBooks/Perspectives
Tutorials
Peer-Reviewed Journals
GEN Biotechnology
Re:Gen Open
New Products
Conference Calendar
Subscribe
Get GEN Magazine
Get GEN eNewsletters
Home
2015
Asuragen
News
Asuragen and Illumina Join Forces on Companion Diagnostics
Cancer
Asuragen to Receive $6.8M from the Cancer Prevention and Research Institute of Texas
News
Asuragen Achieves CE Mark for AmplideX Genetic Test for Fragile X Syndrome
Drug Discovery
Asuragen and Novartis to Facilitate Standardization of BCR-ABL1 RT-qPCR Results
Cancer
Researchers Report Success with Assay Based on Asuragen’s RUO Reagents for NPM1 Mutations in AML Patients
Cancer
Asuragen and Life Technologies Launch BCR/ABL1 Quant Leukemia Test in Europe
Cancer
Asuragen Obtains Rights to BRAF Mutation for Molecular Diagnostics
News
Asuragen to Manufacture RNA Control Kits for Affymetrix to Use in Molecular Diagnostics
Cancer
Asuragen Allies with Clinical Centers to Validate miRNA Pancreatic Cancer Test
News
Asuragen and Life Technologies Pool Resources to Develop CML Diagnostic
1
2
Page 1 of 2
Scroll Up
Scroll Up
